about
Intercellular adhesion molecule 1Protein phosphatase 1 regulatory subunit 16BRAP1B, member of RAS oncogene familyRap guanine nucleotide exchange factor 1Phosphodiesterase 2APhosphodiesterase 4DRap guanine nucleotide exchange factor 2F2R like trypsin receptor 1MARVEL domain containing 2Rap guanine nucleotide exchange factor 3RAP1A, member of RAS oncogene familySRY-box transcription factor 18Myeloid associated differentiation markerPhosphodiesterase 4D, cAMP specificEzrinMoesinRadixinMyeloid-associated differentiation markerPhosphodiesterase 2A, cGMP-stimulatedRap guanine nucleotide exchange factor (GEF) 2Rap guanine nucleotide exchange factor (GEF) 3MARVEL (membrane-associating) domain containing 2Coagulation factor II (thrombin) receptor-like 1Protein phosphatase 1, regulatory subunit 16BRAS-related protein 1aRAS related protein 1bSRY (sex determining region Y)-box 18EzrinRap guanine nucleotide exchange factor 2RAP1B, member of RAS oncogene familyRAP1A, member of RAS oncogene familyIntercellular adhesion molecule 1Phosphodiesterase 4DRap guanine nucleotide exchange factor 3Phosphodiesterase 2AF2R like trypsin receptor 1EzrinProtein phosphatase 1, regulatory subunit 16BSRY-box transcription factor 18Tetraspanin 2A Dmel_CG11415
P682
Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1SOX-18 controls endothelial-specific claudin-5 gene expression and barrier functionTIMAP is a positive regulator of pulmonary endothelial barrier functionThe platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelial barrier function.ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm
P921
Q14891112-149A9F49-7222-4B3E-BB47-E66FE3AB9FDCQ21100622-3C954EFC-F535-4874-A500-D7D6FDFE2C88Q21103244-D65584F0-396C-4829-BF48-B99DCA5F8AC6Q21104809-9A40CBAB-6889-4BAA-A506-DB800783E2FFQ21105011-1BF9FFAF-6B43-462F-9DBC-C6B0D2D0796EQ21106795-1829A21F-B061-4E01-A51A-D2A6F5972C9DQ21107982-9C5130FB-61F9-4E23-BBC4-AB4784FFE395Q21115613-5DC6BB79-2D4C-43FE-A1A9-1F706E29652CQ21120817-D2AFDD57-513B-4E3E-90A0-6EA77D098DC2Q21123225-5019FBD0-9D75-4139-8859-795C4E538E0CQ21124363-48A2BFEA-5B88-41F4-83D3-3CCEAED5D283Q21124524-36295582-17C9-4606-B50A-98E1D7391E96Q21207632-E8C67379-2DD0-45FD-B65A-4EE3E638278BQ21496052-BA8BD205-3A73-44FD-9A84-4CAA894C70A1Q21496347-60406418-E35D-42DC-AC2F-53F76075EC7AQ21496349-E56EB197-0EDD-4D5E-9CFB-EF501A615EF8Q21496351-53EACD1C-6A40-4267-A396-0DAFE4D001A0Q21985820-26144C46-2169-49CD-ACF1-35D8AFBDB1C1Q21985820-32574378-FC25-4A06-89F5-7D50DBFFE4B5Q21985968-4AC6D9F0-03E1-47F4-818A-CD2308D748D3Q21986717-A5692B6A-053F-4A43-8F80-85C53624A94CQ21986718-AA356798-7506-4F70-93BE-86F8CC8BC1BBQ21987217-4230DD5A-218A-4CFE-BB3D-CE6110277CDBQ21987217-E6806509-50D1-4ABC-9A72-D76B9638267EQ21987378-34F82E6A-88D6-45DE-ACFB-CDE5BFB55F78Q21989923-6B7513A3-FF69-471D-A9CC-71970BF610BCQ21989998-6AAEB9FE-A097-4FA4-BD45-3F81CCBAB422Q21990007-DE4D37F0-F2C7-4C3A-808B-9A7C1508854DQ21990150-0EB549D3-625D-4C1D-951B-BCA72C1CD7B4Q22679669-50ED9828-198D-4A75-842B-31936F600A65Q28556909-5143CA1C-6CDD-476A-8102-7EBEC278D17EQ28557283-F4372805-5FA4-465A-94F0-27C47FFCB8C5Q28557562-6DEAB618-1D16-4EF7-B7AF-D232A686A2EAQ28558122-63D2A9DE-07C4-485F-A1BC-D518D7593E80Q28560283-B0F35D58-A514-4CF6-88AA-A19C201B7D01Q28561075-9BBEF5EE-F972-4813-A905-E5B5D458D5D1Q28561596-69209CDE-B3C2-4D14-A981-3D51497C85D0Q28561597-32BDAC34-E368-4DEF-AE91-36D9FDAC3EA6Q28562542-4AB9ECFC-079B-4167-9B1B-88DD22CB5EC0Q29519321-4F46697D-BB3C-4E27-B991-0EFAF35898EB
P682
description
The establishment of a barrier ...... intenance of compartments that
@en
biologisch proces
@nl
name
establishment of endothelial barrier
@en
type
label
establishment of endothelial barrier
@en
prefLabel
establishment of endothelial barrier
@en
P2888
P686
GO:0061028